Clinical Trial Update: Chidamide With Immunotherapy for Patients With Locally Advanced or Metastatic Urothelial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chidamide in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma. The study is currently active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Carcinoma

Drugs mentioned

• Chidamide (chidamide)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Bladder Cancer Stage IV | Phase 2 | Status: ACTIVE_NOT_RECRUITING